Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF Other Liabilities

The latest other liabilities for GNMX is $34M as of September 2019. That compares with $20M in the prior-year period — up 69.5% year over year. Investors often review this figure alongside Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, GNMX's other liabilities moved from $20M to $34M — a 69.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's operating scale or balance-sheet position.

A other liabilities figure of $34M for GNMX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GNMX's other liabilities ($34M), review year-over-year change from $20M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.